BDBM50461077 CHEMBL4228981::US10457637, Compound 60

SMILES CCc1ccc(cc1)N(CC(C)C)S(=O)(=O)c1ccc(N[C@H](C)C2CCOCC2)c(c1)S(C)(=N)=O

InChI Key InChIKey=WDKMUAGGFWOXQT-DKVUXROGSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50461077   

TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Galderma Research & Development

US Patent
LigandPNGBDBM50461077(CHEMBL4228981 | US10457637, Compound 60)
Affinity DataIC50:  550nMAssay Description:The RORγ transactivation model was developed from the line HG5LN, which is a HeLa line that stably expresses a luciferase reporter gene controll...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Galderma Research & Development

US Patent
LigandPNGBDBM50461077(CHEMBL4228981 | US10457637, Compound 60)
Affinity DataIC50:  690nMAssay Description:Inverse agonist activity at RORgamma (unknown origin) expressed in human HeLa-derived HG5LN cells transfected with the GAL4 DNA-binding domain fused ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed